Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?

Detalles Bibliográficos
Autores principales: Monteverdi, Sara, Vita, Emanuele, Sartori, Giulia, Ferrara, Miriam Grazia, D’Argento, Ettore, Tortora, Giampaolo, Milella, Michele, Bria, Emilio, Pilotto, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798740/
https://www.ncbi.nlm.nih.gov/pubmed/35117384
http://dx.doi.org/10.21037/tcr.2019.12.82
_version_ 1784641884689268736
author Monteverdi, Sara
Vita, Emanuele
Sartori, Giulia
Ferrara, Miriam Grazia
D’Argento, Ettore
Tortora, Giampaolo
Milella, Michele
Bria, Emilio
Pilotto, Sara
author_facet Monteverdi, Sara
Vita, Emanuele
Sartori, Giulia
Ferrara, Miriam Grazia
D’Argento, Ettore
Tortora, Giampaolo
Milella, Michele
Bria, Emilio
Pilotto, Sara
author_sort Monteverdi, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-8798740
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87987402022-02-02 Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach? Monteverdi, Sara Vita, Emanuele Sartori, Giulia Ferrara, Miriam Grazia D’Argento, Ettore Tortora, Giampaolo Milella, Michele Bria, Emilio Pilotto, Sara Transl Cancer Res Editorial Commentary AME Publishing Company 2020-02 /pmc/articles/PMC8798740/ /pubmed/35117384 http://dx.doi.org/10.21037/tcr.2019.12.82 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial Commentary
Monteverdi, Sara
Vita, Emanuele
Sartori, Giulia
Ferrara, Miriam Grazia
D’Argento, Ettore
Tortora, Giampaolo
Milella, Michele
Bria, Emilio
Pilotto, Sara
Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title_full Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title_fullStr Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title_full_unstemmed Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title_short Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
title_sort long-term survivors with immunotherapy in advanced nsclc: is ‘cure’ within reach?
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798740/
https://www.ncbi.nlm.nih.gov/pubmed/35117384
http://dx.doi.org/10.21037/tcr.2019.12.82
work_keys_str_mv AT monteverdisara longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT vitaemanuele longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT sartorigiulia longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT ferraramiriamgrazia longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT dargentoettore longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT tortoragiampaolo longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT milellamichele longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT briaemilio longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach
AT pilottosara longtermsurvivorswithimmunotherapyinadvancednsclciscurewithinreach

Ejemplares similares